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ABSTRACT

In this study I investigated the effects of 192-lgG saporin injections into the medial
septal area. (MSA) and nucleus basalis magnocel/ularis (NBM) on radial arm maze
performance in the male rat. The results of the present study reveal that combined
injections of 192-lgG saporin into the basal forebrain failed to disrupt RAM performance
when compared to vehicle-injected controls. In addition, intraperitoneal injections using a
muscarinic receptor blocker, scopolamine, failed to reveal a compensatory response of the
cholinergic basal forebrain that may have explained the lack of behavioral effects of 192
IgG saporin. Consequently, the results of this study suggest that a selective reduction in
cholinergic transmission in the basal forebrain is, by itself, insufficient to account for the
functional impairments observed in spatial learning in the rat. These data do not support
the use of 192-lgG saporin as a viable approach to the elucidation of the
neuropathological mechanisms that are associated with the cognitive deficits seen in
Alzheimer's Disease.

Basal Forebrain Lesions and Memory

4

Alzheimer's disease (AD) is a neurodegenerative disorder that currently afflicts
approximately 4 million people in the United States, with roughly 100,000 new cases
diagnosed ~ach year

19.

cognition, and personality

AD is characterized by progressive deterioration of memory,
19.

Pathologically, the hallmarks of AD are the appearance of

neuritic plaques and neurofibrillary tangles in various regions of the brain, and extensive
neuronal damage and loss
of the etiology of AD

12,18,39,

40.

While progress has been made toward an understanding

currently there is no animal model that mimics the profound

pathological and behavioral deficits that characterize the disease. For this reason, our
laboratory has focused on the behavioral changes that occur in animals who receive
bilateral injections of different fragments of B-amyloid (the major constituent of the neuritic
plaque, a pathological hallmark of AD) into the hippocampus.

We have previously

reported that bilateral injections of B-amyloid in the hippocampus along with a
subthreshold dose of the neurotoxin ibotenic acid induce a dramatic impairment in the
acquisition of spatial learning in the rat

9.

Another approach that our laboratory has taken

recently is to mimic the loss of the cholinergic projections to the hippocampus and cortex
using a variety of lesion techniques and to determine how the loss of these fibers affects
learning and memory in the rat. The latter approach is the focus of my project.
In AD patients, there is a decrease in the amount of cholinergic input from the
basal forebrain to the hippocampus and cortex

15.

A correlation between this gradual

depletion and the learning and memory deficits characteristic of AD patients has been
reported in several studies 13,31,33. The resulting theory, called the cholinergic denervation
hypothesis of AD, infers a causal relationship between the loss of acetylcholine (ACh) in

-

~
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the cortex and hippocampus, and the cognitive deficits. In support of the cholinergic
hypothesis, these affected areas are intimately involved in learning and memory.
The most prominent projection in the mammalian basal forebrain is a projection
from the medial septal area (including the diagonal band of Broca) to the hippocampus,
in addition to a cortical projection that originates from the nucleus basalis magnocellularis
25.

Collectively, these t\NO areas account for approximately 80-90% of the cholinergic input

to the hippocampus and cortex respectively. Accumulating evidence from a large number
of studies done in the rat reveal that disruption of the functional integrity of the cholinergic
basal forebrain (CBF) projection to the hippocampus and cortex using cholinergic
antagonists

22,30,

or specific lesions of the medial septal area (MSA) and nucleus basalis

magnocellularis (NBM), induce marked impairments of a variety of behavioral tasks,
particularly those that involve spatial learning

2,6-8,14,26.

More specifically, consid~rable

evidence suggests that, on the average, lesions of the MSA or NBM induce substantial
spatial learning impairments on both the Morris water maze (MWM) and the radial arm
maze (RAM).

These impairments are associated with marked reductions in choline

acetyltransferase (ChAT), which is an index of cholinergic activity.
In the past, many of the lesions of the MSA or NBM have been done using
relatively non-selective techniques. For example, in addition to the inherent problem of
damage to "fibers of passage," electrolytic lesions of the NBM often induce damage to
surrounding area (e.g. globus pallidus), and not only reduce cholinergic transmitters, but
other neurotransmitters as well. This is particularly problematic with MSA and NBM
lesions as cholinergic neurons in these areas are scattered among a plethora of non
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cholinergic neurons. While the use of excitotoxins circumvent many of the problems
inherent with electrolytic lesions, most induce considerable damage to adjacent structures
via significant diffusion from the injections site. Not surprisingly, when studies have been
done using the aforementioned techniques to assess the effects of lesions of the N8M and
MSA on spatial learning in the rat, conflicting results have been reported. For instance,
although marked impairments of spatial learning have been observed on performance of
either the radial arm maze or morris water maze

23,26,27,

others have found either no

appreciable effects 24.32 or differential effects when assessing spatial learning with either
the radial arm maze or the morris water maze 6 depending on the excitotoxin used. These
studies have seriously questioned previous interpretations of spatial learning impairments
induced by ibotenic acid in terms of cholinergic loss.

Several investigators have

suggested that the spatial impairments observed following excitotoxic lesions of the basal
forebrain may be resulting from loss of non-cholinergic neurons

11.

Not surprisingly, there has been pressure to develop neurotoxins specific to the
cholinergic system. One such neurotoxin, called ethylcholine aziridinium mustard ion
(AF64A) was introduced by Dr. Israel Hanin about ten years ago. AF64A is selectively
taken up by cells with choline uptake sites. AF64A produces reliable impairments on a
variety of spatial tasks, and has been proposed as a model of the cholinergic denervation
of AD

29,34.

More recently, saporin, a specific neurotoxin, has been developed. Saporin

is a ribosome-inactivating protein derived from the fern Saporin offininalis, and when
coupled to a monoclonal antibody against the p7510w affinity nerve growth factor receptor
(NGFr) is a selective cholinergic toxin (192-lgG-saporin) 45. Within the basal forebrain, the
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p75 NGFr is located exclusively on cholinergic cell bodies in the MSA and NBM that
project to the hippocampus and cortex, but not to the amygdala

16.

Intraventricular

injections of 192 IgG saporin cause, by seven days, a permanent 80-90% depletion of
acetylcholine levels in the cortex and hippocampus, while having minimal effects on other
transmitter systems

5.

192-lgG-Saporin seems an idea tool for studying the components of the basal
forebrain cholinergic system as they relate to memory, since it can be injected both
intraventricularly and directly into the areas where a lesion is desired. However, although
the neurotoxic effects of 1921gG-saporin are specific, the effects of saporin injections into
the basal forebrain on learning and memory have produced inconsistent results. In the
first published study on the effects of 192-lgG saporin on spatialleaming in the rat, Nilsson
et al

30

reported that intraventricular injections of 192-lgG saporin which produced ~ 85

90% reduction of ChAT activity in the hippocampus, induced a long-lasting deficit on water
maze performance in female rats when compared to controls. However, a subsequent
study by Torres et al

41

found that, following intraventricular injections, there was a 70-90%

depletion of AChE in the hippocampus and cortex but no deficits in water maze
performance. A study by Baxter et al

3

showed that neither NBM lesions nor MSA lesions

had any effect on water maze performance, although they too found a marked depletion
of cholinergic markers.

In contrast, Berger-Sweeney et al

4,

after finding the same

cholinergic depletions, found that the intraventricular and NBM lesions caused deficits in
water maze performance, while the MSA lesion had hardly any effect. Clearly, the above
studies indicate that despite consistent reductions of ChAT activity in the basal forebrain
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following injections of 192-lgG saporin, a wide disparity of effects on spatial learning in the
rat exists following injections of 192-lgG saporin. For example, thus far at least 4 studies
have been pl:Jblished 3.4,37,38 that have reported a lack of effect on spatial learning in the rat
despite a 70-90% reduction of basal forebrain acetylcholine. In the studies that have
reported an impairment of spatial learning following intraventricular injections of saporin,
all have noted that the effects observed may be due to loss of cerebellar NGFr-positive
Purkinje cells following intraventricular injections of 192-lgG saporin. In a recent article
published by Walsh et al 43, the authors conclude that although 192-lgG saporin is a highly
selective cholinergic toxin, the secondary effects induced by intraventricular injections of
192-lgG saporin "makes the i.c.v. model of 192 IgG saporin problematic for studying the
role of the CBF in normative behavior and in disease states." The authors further suggest
that site-specific injections of 192-lgG saporin would provide a viable approach to 1T!0dei
Alzheimer's Disease.

In order to circumvent the problem of cerebellar Purkinje cell

damage following i.c.v injection of 192-lgG saporin, while at the same time producing a
cholinergic lesion that essentially destroys the cholinergic input to the hippocampus and
cortex in the rat, we have employed a "combined lesion" technique where the animals
receive stereotaxic injections into the medial septal area, and (bilateral) injections into the
nucleus basalis magnocellularis. These injections produce very selective lesions of the
CBF while at the same time avoiding the inherent problems associated with intraventricular
injections of 192-lgG saporin.
In a previous study done in this lab using the "combined lesion" approach

10,

we

investigated the effects of 192-lgG saporin injections into the MSA, NBM, or combined
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injections into the MSA and NBM on water maze and radial arm maze performance in the
male rat. We reported a dissociation between the effects of 192-lgG saporin injections
into the basal forebrain on the performance of the two tasks of spatial learning in the rat.
Bilateral injections of 192-lgG saporin into the NBM, MSA, or combined MSAlNBM failed
to disrupt water maze performance when compared to controls. In contrast, injections of
192-lgG saporin into the MSA, NBM, or MSAlNBM induced impairments on the radial arm
maze task. Overall, the disruption of spatial learning observed in this study was relatively
mild compared to deficits in spatial learning reported using less selective lesions of the
cholinergic basal forebrain.
The current project attempts to expand upon the previous study. In addition to the
single MSA and bilateral NBM injections, we added a second group that received two
additional injections of 192-lgG saporin into the MSA (bilateral), to determine whet,her a
more complete lesion of the MSA (and thus a greater depletion of acetylcholine) will
disrupt performance of a radial arm maze spatial memory task.
All of the studies that have been published using saporin have assessed
acquisition of spatial tasks. Perhaps more profound effects of selectively disrupting the
cholinergic system would be observed in animals that have already learned the task.
Therefore, in this study, in addition to more extensive lesions of the cholinergic basal
forebrain, the animals were pretrained on the radial arm maze. After they established
criteria, they were given the 192-lgG saporin injections and retested on the radial arm
maze. The partially baited paradigm allows measurement of both reference memory
(vvhich arms are baited throughout all trials) and recent memory (the running list of which
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arms have and have not been visited during a trial). A modified version of the RAM task
was used in the second experiment, in which the trial was interrupted by a five-minute
delay after th~ rat had visited three baited arms. This allows for measurement of two kinds
of recent memory: retroactive (the rat's memory of which three baited arms it has visited
before the delay) and proactive (its memory of arms visited during the postdelay session).

METHODS:
Animals
Thirty-four male Long-Evans rats, obtained from Harlan Sprague-Dawley, ranging
in age between 4 and 6 months and weighing approximately 250-350 g were used in this
The rats were individually housed in hanging stainless steel cages ,in a

study.

temperature-controlled environment (20°C) on a 10:14 lightdark cycle (lights on a 0600
and off at 2000). During radial arm maze testing before and after surgery, all animals were
food deprived to 85% their ad libitum weight.

Surgery
Once all animals had established criteria (Le., group means of < 2 recent memory
errors and

~

1 reference memory errors), they were brought back to their ad libitum

weights in preparation for surgery. The animals were assigned to four groups such that
the mean performance of all measures (reference and recent memory errors, and choice
latency) in every group was statistically identical. Since it has been demonstrated that
injections of 192-lgG alone do not produce neurotoxic damage, or effects on spatial
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learning

4,45,

all control injections were done using the 0.05% sodium azide solution (0.6

1J1/per injection). At this dose, sodium azide does not affect spatial learning

10.

Each rat

was anesthetized with sodium pentobarbitol (50 mglkg) and received stereotaxic injections
via a 1 IJL Hamilton syringe of O.84IJg/IJL of 192-lgG saporin (Lot # 31795031, Chemicon)
dissolved in a 0.05% sodium azide solution. One half of the animals received two bilateral
injections into the nucleus basalis magnocellularis (AP: -o.8mm; ML: +3.6mm; DV: -5.9mm)
and one injection into the medial septal area (AP: +1.8mm; ML: Omm; DV: -6.0mm). The
other half received these injections plus two additional injections into the medial septal
area (AP: +1.8mm; ML: +1.0, -1.0mm; DV: -7.0mm). All coordinates are from dura.
In order to prevent backflow and minimize tissue damage, all injections took place
over a three minute interval, and the needle was left in place after the injection for an
additional five minutes. The needle was also raised and lowered over an interval of four
minutes. The coordinates for all injections were empirically determined using the Atlas of
Paxinos and Watson as a guide

35.

Apparatus and Behavioral Testing
Experiment 1: Standard RAM Task
The testing apparatus consisted of a partially baited 8-arm (5 arms baited) radial
arm maze (RAM). Prior to surgery, all animals were trained to perform the RAM task to
criteria, which was designated as making no more than two errors. The animals were
exposed to a habituation period of four days, during which reinforcers (cheerios) ,were
liberally scattered on the RAM. Three animals were placed on the center platform and
allowed to explore for 5 minutes. Following the adaptation phase, each animal was tested
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alone over a period of three weeks until it met criteria. The RAM consisted of 8 arms, of
which 5 were baited with reinforcers. The baited and unbaited arms remained constant
throughout the experiment. At the beginning of the RAM task, each animal was placed in
the center of the maze and permitted to choose among the arms until it had successfully
completed the task (obtained all five reinforcers), or until five minutes had elapsed. The
following behavioral parameters were recorded: 1) recent memory errors: total number of
reentries into any arms, 2) reference memory errors: first entry into arms that were never
baited, and 3) choice latency, calculated by dividing total trial latency by the total number
of choices.
Six days after the animals had reached criteria, stereotaxic surgery was performed.
Following a two week recovery period, all animals were given at least three trials to
reestablish a baseline performance on the RAM. If the animal did not complete the, task
within five minutes, it was removed from the maze and the data from that trial was not
counted in the final analyses. Testing continued for a total of sixteen days, with a two
week break between the twelfth and thirteenth day of testing.

Experiment 2: Delay Condition
Following completion of the standard testing, there was a 5 minute delay imposed
in the middle of the trial. The rat was allowed to find three of the reinforcers, then removed
from the maze and made to wait five minutes in the carrier. The rat was then returned to
the maze, and only the two of the original five arms remained baited (the two it had not
previously visited). The rat was then allowed to run until it had found the remaining
reinforcers.

The following parameters from the postdelay session of the trial were
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recorded: 1) Reference memory errors: entry into an arm that was never baited; 2)
Retroactive memory errors: entry into an arm that had been baited and visited during the
predelay session; 3) Proactive memory errors: reentries into any arm. Animals that did not
finish either the predelay or postdelay task within five minutes were excluded from the
analysis for that day. Testing continued for a total of nine days. There was an added
distraction as well; in the break between experiment one and two there was a central
"doorway" which included guillotine doors leading to each arm installed onto the maze.
These were not used during the course of the remaining experiments and were kept open
at all times.

Scopolamine Treatment and Behavioral Testing
Following the completion of the delay testing, all animals were randomly assigned
to receive one of three drug treatments. They received an IP injection of either sterile
saline, scopolamine at a low dose (0.03mglkg), or scopolamine at a high dose (0.3 mg/kg).
Fifteen minutes after the injections, the animals were again tested on the RAM, with a five
minute delay between the third and forth choices. Animals were tested again two days
later, after the drug had worn off, to ensure that there were no carryover effects from the
injections. They then received another different dose of the drug, followed by the RAM test
immediately after and two days later. Animals in this way received two doses of the drug
and one control injection.

Neurochemical Analysis and Histological Verification and ChAT Analysis:
The brains of the animals will be processed following completion of the testing.
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RESULTS:
Of the 34 animals that began the experiment, one died of an infection unrelated to
the saporin lesions during Experiment 2. That animal's data was included up to the point
that it could no longer run (in block 2). That left 33 animals for data analysis: MSA (1)/
NBM (saporin), n=12; MSA (3)/ NBM (saporin), n=11; MSA (1)/ NBM (vehicle), n=5; and
MSA(3)/ NBM (vehicle), n=5.
Experiment 1:
Animals were tested for sixteen days. All scores were summed and averaged over
blocks comprised of two days per block. It was clear that the

two control groups did not

differ in their performance during the first few blocks, and separate ANOVA's by injection
site in the control groups did reveal a non significant difference (p >0.05). All subsequent
data for the two groups were combined and the group collectively referred to as "controls."
The mean number of reference memory errors and recent memory errors during
the eight blocks of standard RAM testing are illustrated in Figures 1a and 1b, respectively.
The average latency per choice is shown in Figure 1c.
A 3 x 8 mixed ANOVA with blocks as the repeated measure and injection condition
as the between measure revealed a significant main effect of injection site for reference
memory errors, F(2,64) = 6.12, P < 0.003.

However, the analysis revealed a non

significant block by injection condition interaction F(14, 448)= 1.19, p> 0.05. Pas hoc
analysis revealed that on blocks 5 and 7, the MSA 1/NBM group was significantly different
from the MSA 3/ NBM group, and on block 6, the control group was significantly different
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than the MSA 3/ NBM group.

Analysis of recent memory errors revealed no main effect, F(2,64) = 0.14, P > 0.05,
and no interCiction, F(14, 448=1.49), P > 0.05. This demonstrated that saporin injections
into the MSA and NBM combined had no effect on recent memory as measured by the
RAM task.
Analysis of choice latency showed both a significant main effect of injection site,
F(2,64) = 7.06, P < 0.002.

There was also significant block by injection condition

interaction F(14,448) = 2.28, P < 0.005. Post hoc analysis revealed that, overall, the
animals with 3 injections to the MSA and 2 to the NBM had significantly faster choice
latencies than the other two groups on all blocks except 5 and 8. This is illustrated in
Figure 1c.
Experiment 2:

Animals 'Nere tested for a total of nine days, and the data was combined into blocks
of 3 days per block.

Mean reference memory errors, retroactive errors, and proactive

errors, are displayed in Figure 2a, 2b, and 2c, respectively.
A 3 x 3 mixed ANOVA with blocks as the repeated measure and injection condition
as the between variable on reference memory errors revealed a non-significant main effect
of injection condition, F(2,99) = 0.15, P > 0.05. There was also a non-significant block by
injection condition interaction, F(4,198 )=0.25, P > 0.05. The results show that 192
Saporin lesions of the MSA and NBM had no significant effect on performance of the .RAM
task 'Nhen compared to controls, even after a delay of five minutes was imposed during the
middle of the trial.
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Likewise, analyses of retroactive errors and proactive errors also revealed non
significant main effects of injection conditions, F(2,99) = 0.401, p>0.05; and F(2,99) = 0.08,
p> 0.05, respectively. It also revealed non-significant interactions of block and injection
condition F(4, 198) = 0.34,P>0.05; and F(4,198)= 0.34, p>0.05.
Analysis of choice latency revealed a non-significant main effect of injection
condition, F(2,99)=0.91, p>0.05, and a non-significant interaction, F(4, 198)=0.90, p> 0.05.
(graph not shown).
Overall, these data indicate that 192-lgG saporin, injected into the basal forebrain,
had no effect on any of the measures of this task in rats when compared to vehicle-injected
controls.
Experiment 3:

Figure 3a, 3b, and 3c illustrate reference memory errors, retroactive memory
errors, and proactive errors in animals which have received either saline or scopolamine
injections fifteen minutes prior to the trial.
A 3 x 3 mixed ANOVA with injection condition as the first between variable and
scopolamine dose as the within variable on reference memory errors revealed a non
significant main effect of injection condition, F(2,30)=2.95, p> 0.05, and a non-significant
injection condition by scopolamine dose interaction F(4,60)=0.25, p> 0.05.
A similar analysis of retroactive memory errors also revealed a non-significant main
effect of injection condition, F(2,30)=0.17, p > 0.05, as well as a non-significant injection
condition by scopolamine dose interaction, F(4,60)=1.15, p > 0.05.

An analysis of proactive errors did reveal a significant main effect of injection site,

-
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F(2,30)=4.54, P < 0.02, as well as an injection site by scopolamine dose interaction,
F(4,60)=4.54, p < 0.003. Post hoc analysis of proactive errors, however, revealed that the
interaction was only seen using the highest dose of scopolamine. The MSA 1/ NBM group
made significantly more errors than did the MSA 3/ NBM or control groups. There were
no differences between the MSA 3/ NBM and control group at the highest dose, nor were
there any differences between groups at either the saline or the low scopolamine dose.
Analysis of choice latencies (graph not shown) did not reveal a significant main
effect, F(2,30)=1.86, p > 0.05. It did not reveal any injection condition by scopolamine
dose interaction either, F(4,60)=1.09, p > 0.05.
Overall, there were no significant differences between the 192-lgG saporin
lesioned animals and the controls at either the saline or the low dose of scopolamine. The
only parameter significantly affected at the high dose was the proactive errors.
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DISCUSSION:

The results of this study did not show any appreciable deficit of either recent or
reference memory as measured by the RAM task following lesions of the basal forebrain
using 192-lgG-saporin. The first experiment showed that the MSA 3/ NBM 2 group made
significantly faster choices vvhen compared to the two other groups, but otherwise there
were no differences between groups on any other measures.
In the light of other studies using saporin, these results are neither surprising nor
unexpected. Another study conducted in our lab at the same time as this one, in vvhich
saporin from the same batch was used to lesion the MSA only, revealed that the saporin
caused a marked depletion of AChE levels in the hippocampus, showing the saporin was
working. We are thus reasonably certain that there was a marked cholinergic depletion
in our animals, although we have not yet confirmed this with either neurochemical or
histological analyses.
There are a number of factors that may explain our not seeing an impairment. A
study by Waite et al

42

concluded that at least a 85-95% depletion of ChAT was necessary

before a behavioral impairment would be seen. They compared it to the >90% loss of
dopaminergic neurons needed before the behavioral symptoms of contralateral turning
become apparent (in the rat model of Parkinson's Disease). They suggest that perhaps
this is the reason that the quisqualic and AMPA lesions of the NBM also did not produce
a behavioral deficit, since they only depleted ChAT by 70-80%. It is possible that, even
in our animals with five lesions, we did not induce a large enough depletion of ACh to see
a deficit and that the brain was able to compensate for the loss.

-
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If this was the case, however, we expected that we would see an impairment
following injections of a subthreshold dose of scopolamine, just as Steckler et al had
expected

20..

We believed that scopolamine would cause a greater deficit on the RAM in

the 192-lgG saporin lesioned animals than in controls. In our other study, rats with MSA
lesions only did show greater memory deficits when given subthreshold doses of
scopolamine.

Since the subthreshold dose had no measurable effects on our rats, we

cannot conclude anything from that experiment.
However, the "compensation" explanation does not explain why such profound
deficits are seen with general antagonists like scopolamine or other excitotoxins such as
ibotenic acid, which produce the same amount of cell loss and cholinergic depletion as
quisqualic acid and AMPA.

One plausible explanation is that scopolamine affects

peripheral ACh receptors as 'Nell. These include cholinergic systems controlling salivation,
heart rate, gastrointestinal motility, temperature, blood pressure, and efficient functioning
of the lungs and bronchial tract

1.

Animals on high doses of scopolamine not only exhibit

motor and breathing problems, but their dry mouths prevent them from eating the
reinforcers. In this study, only 50% of the rats on the high dose of scopolamine were able
to complete the task. Thus, the observed deficits may be less attributable to memory
deficits, and more due to the side effects.
Another explanation is that excitotoxic damage is nonspecific. In fact, nearly every
study using saporin that has found behavioral deficits has used either intraventricular
injections (known to affect cerebellar PUrkinje cells) or has been at a high enough dose to
affect other neurotransmitters as well

43.

These results, along with numerous studies

•
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involving manipulations of other transmitters in combination with acetylcholine, clearly
show the involvement of other neurotransmitter systems in learning and memory. There
is evidence for interactions between the cholinergic system and other systems such as
serotonergic, GABAergic, and noradrenergic systems

6,17,28,36.

Numerous studies have

also shown that lesions to the NBM produce deficits on attentional tasks, leading Wellman
et al

44

to conclude that the deficits induced by NBM lesions may be mediated by attention

and motivation.
Given the evidence against the exclusive role of ACh in learning and memory, it
is somewhat surprising that most of the therapeutic drugs currently being tested for AD are
specific to acetylcholine.

In fact, drugs such as tacrine (Cognex), physostigmine,

velmacrine, and others are currently being used to treat patients with the disease

21.

These drugs work by increasing the amount of acetylcholine available in the affected
areas of the brain, and they are meeting with limited success. Part of the reason for the
failure of these drugs is that their mode of action is presynaptic. As AChE inhibitors, they
prevent the breakdown of ACh and allow more of it to remain in the cleft. Unfortunately,
in Alzheimer's Disease, the presynaptic fibers are degenerating. Thus there is less ACh
present to begin with. AChE inhibitors may be useful in early stages of the disease, but
for later stages there is not enough ACh for them to act on.
One final possibility for our not finding behavioral deficits was that we may not have
been using the right tests. As mentioned earlier, most of the saporin studies tested
acquisition. We decided to test retention, our rationale being that any deficits we found
would be due to the lesion, not due to a slower-learning group. By pretraining the rats,
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we may have made the task too familiar. If the MSA and NBM are involved in acquisition
and consolidation of events, then we of course would not have seen deficits. The second
experiment was designed to control for that effect by introducing a new trial-specific
element by interrupting the task and forcing the rats to remember where they had been
before on that day. It may be that five minutes was not a long enough delay for effects to
be seen.
In conclusion, further studies on the interaction of neurotransmitter systems and
the cholinergic system are warranted.

While selective depletion of acetylcholine by

saporin is not in itself a good model for AD, it will be incredibly useful in conjunction with
toxins specific to other systems for determining these possible interactions. We plan to
study the GABA system next, by giving these animals a GABA enhancing drug and testing
them on the water maze.
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FIGURE LEGENDS:

Figure 1:
A: Effects of combined immunolesions using 192-lgG Saporin on mean number of
reference memory errors (entries into unbaited arms) during a standard partially-baited
RAM task by male rats.

B. Effects of combined immunolesions using 192-lgG saporin on mean number of recent
memory errors (reentries into arms) during a standard partially-baited RAM task by male
rats. Mean number of recent memory errors (reentries into arms). C. Effects of combined
immunolesions using 192-lgG Saporin on the average latency per choice (total trial latency
divided by number of choices) during a standard partially-baited RAM task by male rats.
Each rat received one trial per day for sixteen days. Vertical lines represent standard
errors. Groups are as follows: MSA 1/ NBM 2, n=12; MSA 3/ NBM 2, n=12; Controls,
n=10. (*) indicates significantly different from the MSA 3/ NBM 192-lgG saporin lesioned
group.

(-) indicates significantly different from both other groups. (-) indicates

significantly different from the MSA 1/ NBM 192-lgG saporin lesioned group.

Figure 2
A: Effects of combined immunolesions of the MSA and NBM on the mean number of
reference memory errors (entries into arms that were never baited) during performance of
a standard RAM task with a five-minute delay between the third and forth choices. B:
Effects of combined immunolesions of the MSA and NBM on the mean number of
retroactive memory errors (entries into unbaited arms that were baited and visited during
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the pre-delay session of the trial) during performance of a standard RAM task with a five
minute delay bet\Yeen the third and forth choices. C: Effects of combined immunolesions
of the MSA and NBM on the mean number of proactive errors (reentries into any arm
during the post delay session) during performance of a standard RAM task with a five
minute delay bet\Yeen the third and forth choices. Vertical lines represent standard errors.
Groups are as follows: MSA 1/ NBM 2, n=12; MSA 3/ NBM 2, n=11; Controls, n=10.

Figure 3:
A: Effects of two doses of scopolamine on the mean number of reference memory errors
(entries into arms that were never baited) during performance of a standard RAM task with
a five minute delay by rats with combined immunolesions of the MSA and NBM. B: Effects
of two doses of scopolamine on the mean number of retroactive memory errors (entries
into unbaited arms that were baited and visited during the pre-delay session of the'trial)
during performance of a standard RAM task with a five minute delay by rats with combined
immunolesions of the MSA and NBM. C: Effects of two doses of scopolamine on the
mean number of proactive errors (reentries into any arm during the post delay session)
during performance of a standard RAM task with a five minute delay by rats with combined
immunolesions of the MSA and NBM.

Each rat received one tr'ial per day for nine days.

Vertical lines represent standard errors. Groups are as follows: MSA 1/ NBM 2, n=12;
MSA 3/ NBM 2, n=11; Controls, n=10. (*) indicates that this group was significantly
different from both of the other

two groups.
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